Swedish Orphan Biovitrum (Switzerland)

Efficacy and safety of emapalumab in macrophage activation syndrome

Fabrizio De Benedetti, Alexei A. Grom, Paul Brogan et al. · Annals of the Rheumatic Diseases · 2023 · 141 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14

Predictive potential of tumour-stroma ratio on benefit from adjuvant bevacizumab in high-risk stage II and stage III colon cancer

Stéphanie M. Zunder, Gabi W. van Pelt, Hans Gelderblom et al. · British Journal of Cancer · 2018 · 36 citations · Full text

Medicine, Oncology, Cancer Pharmacology +14

Emapalumab in primary haemophagocytic lymphohistiocytosis and the pathogenic role of interferon gamma: A pharmacometric model‐based approach

Philippe Jacqmin, Christian Laveille, Eric Snoeck et al. · British Journal of Clinical Pharmacology · 2021 · 32 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Interferon-gamma driven elevation of CXCL9: a new sepsis endotype independently associated with mortality

Evangelos J. Giamarellos‐Bourboulis, Massimo Antonelli, Frank Bloos et al. · EBioMedicine · 2024 · 22 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Emapalumab treatment in an ADA-SCID patient with refractory hemophagocytic lymphohistiocytosis- related graft failure and disseminated bacillus Calmette-Guérin infection

Francesca Tucci, Vera Gallo, Federica Barzaghi et al. · Haematologica · 2020 · 20 citations · Full text

Pharmacy, Hematology, Pharmacotherapy +17